[Translated article] Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis

[Translated article] Effectiveness and Drug Survival of Apremilast in 65 Patients With Psoriasis and/or Psoriatic Arthritis

Bibliographic Details
Main Authors:	P. Garbayo Salmons, V. Expósito Serrano, J. Romaní de Gabriel, M. Ribera Pibernat
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	Actas Dermo-Sifiliográficas
Online Access:	http://www.sciencedirect.com/science/article/pii/S0001731022002915

Similar Items

Estudio de eficacia y supervivencia de apremilast en 65 pacientes con psoriasis y artritis psoriásica
by: P. Garbayo Salmons, et al.
Published: (2022-05-01)

Hidradenitis supurativa tratada con apremilast: serie de casos
by: P. Garbayo-Salmons, et al.
Published: (2021-11-01)

[Translated article] Red Ear: A Poorly Understood Syndrome
by: P. Garbayo-Salmons, et al.
Published: (2022-12-01)

Apremilast: target synthetic drug for the treatment of psoriatic arthritis and psoriasis
by: Yu. L. Korsakova, et al.
Published: (2018-07-01)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
by: Forchhammer S, et al.
Published: (2015-09-01)

THE EFFICACY AND SAFETY OF THE NEW DRUG APREMILAST FOR THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2016-12-01)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
by: Palfreeman, A, et al.
Published: (2013)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
by: Palfreeman AC, et al.
Published: (2013-03-01)

El síndrome de la oreja roja: un gran desconocido
by: P. Garbayo-Salmons, et al.
Published: (2022-12-01)

Clinical experience with apremilast for psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2018-09-01)

Clinical potential of apremilast in the treatment of psoriatic arthritis
by: Cauli A, et al.
Published: (2014-06-01)

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
by: Haddad A, et al.
Published: (2023-10-01)

Acrodermatitis continua of Hallopeau with psoriatic arthritis treated with biologics and apremilast
by: Shohei Igari, et al.
Published: (2023-09-01)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

Herpes Zoster, Hepatitis C, and Tuberculosis Risk with Apremilast Compared to Biologics, DMARDs and Corticosteroids to Treat Psoriasis and Psoriatic Arthritis
by: Hagberg KW, et al.
Published: (2020-02-01)

Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
by: Ashis K. Das, et al.
Published: (2023-07-01)

The efficacy and safety of apremilast in patients with psoriatic arthritis concurrent with comorbidity in clinical practice
by: E. Yu. Loginova, et al.
Published: (2019-07-01)

Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic
by: Ashis K. Das, et al.
Published: (2023-07-01)

Apremilast for lithium-associated psoriasis
by: Joohyung Youh, et al.
Published: (2022-01-01)

Erythrodermic psoriasis treated with apremilast
by: John Arcilla, et al.
Published: (2016-09-01)

Methotrexate in psoriasis and psoriatic arthritis
by: Coates, L, et al.
Published: (2020)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: V. Ibba, et al.
Published: (2011-09-01)

EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M.A. Cimmino
Published: (2011-09-01)

Genetics of psoriasis and psoriatic arthritis
by: Chandran Vinod
Published: (2010-01-01)

[Translated article] Windmill Flap: A New Reconstructive Option
by: P. Garbayo-Salmons, et al.
Published: (2024-02-01)

Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis
by: Dafna D. Gladman, MD, et al.
Published: (2020-01-01)

Immunogenicity to biological drugs in psoriasis and psoriatic arthritis
by: Fernando Valenzuela, et al.
Published: (2021-10-01)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
by: Mease, PJ, et al.
Published: (2020)

APREMILAST: AN UPDATE ON ITS EFFICACY AND SAFETY DURING LONG-TERM TREATMENT OF PATIENTS WITH PSORIATIC ARTHRITIS
by: Yu. L. Korsakova, et al.
Published: (2018-11-01)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: S. V. Smirnova, et al.
Published: (2014-08-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Identification of psoriatic arthritis in patients with psoriasis
by: Coates, LC, et al.
Published: (2023)

EXTRACORPOREAL PHOTOCHEMOTHERAPY IN PSORIASIS AND PSORIATIC ARTHRITIS
by: E. S. Yakubovskaya, et al.
Published: (2016-06-01)

Psoriasis, Psoriatic Arthritis, and Thyroid Autoimmunity
by: Ilaria Ruffilli, et al.
Published: (2017-06-01)

Psoriasis and psoriatic arthritis: Topical issues
by: Yulia Leonidovna Korsakova
Published: (2012-09-01)

Cardiovascular risk factors in psoriatic disease: psoriasis psoriatic arthritis
by: Nuria Barbarroja, et al.
Published: (2019-10-01)

Recurrence of Melanoma after Starting Apremilast for Psoriasis
by: Thomas G. Salopek
Published: (2017-08-01)

ENTHESITIS AND PSORIATIC ONYCHOPATHY AS A FACTOR FOR PREDICTION OF PSORIATIC ARTHRITIS IN PSORIASIS
by: Tatyana G. Sidorcika, et al.
Published: (2018-04-01)

GENETIC FACTORS IN IMMUNOPATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
by: M. V. Smolnikova, et al.
Published: (2014-08-01)

COMORBIDITIES IN PSORIATIC ARTHRITIS AND PSORIASIS: CONSIDERATIONS FOR THE CLINICIAN
by: Lucia Dutca, et al.
Published: (2023-12-01)